DOCUMENTS
AGREEMENT PRESS RELEASE
Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians
Published by the United States Department of Justice | View article on www.justice.gov
Pharmaceutical company Novartis Pharmaceuticals Corporation (Novartis), based in East Hanover, New Jersey, has agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims Act (FCA).